A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Elicio Therapeutics
Shanghai Bao Pharmaceuticals Co., Ltd.
Carisma Therapeutics Inc
UTC Therapeutics Inc.
Celldex Therapeutics
Chongqing Precision Biotech Co., Ltd
Xencor, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Case Comprehensive Cancer Center